Macrolide-resistant Streptococcus pyogenes in Central Greece: Prevalence; mechanism and molecular identification

International Journal of Antimicrobial Agents

Volumn 35, Issue 6, 2010, Pages 614-615

  Malli, Ergina ^a   Tatsidou, Evi ^a   Damani, Anthi ^a   Pantelidi, Kleoniki ^a   Petinaki, Efthimia ^a   Skoulakis, Charalambos ^b   Drougka, Eleanna ^c   Spiliopoulou, Iris ^c  

^a UNIVERSITY OF THESSALY   (Greece)

^b General Hospital of Volos   (Greece)

^c UNIVERSITY OF PATRAS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CEFOTAXIME; CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; GATIFLOXACIN; MACROLIDE; PENICILLIN G; TEICOPLANIN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; DISK DIFFUSION; GENOTYPE; GREECE; HUMAN; LETTER; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; STREPTOCOCCUS PYOGENES;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; DRUG RESISTANCE, BACTERIAL; GENOTYPE; GREECE; HUMANS; MACROLIDES; PREVALENCE; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 77951768899     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.01.025     Document Type: Letter

References (7)

1. Petinaki E., Kontos F., Pratti A., Skulakis C., Maniatis A.N. Clinical isolates of macrolide-resistant Streptococcus pyogenes in Central Greece. Int J Antimicrob Agents 2003, 21:67-70.
2. Silva-Costa C., Ramirez M., Melo-Cristino J. Identification of macrolide-resistant clones of Streptococcus pyogenes in Portugal. Clin Microbiol Infect 2006, 12:513-518.
3. Amezaga M.R., McKenzie H. Molecular epidemiology of macrolide resistance in β-haemolytic streptococci of Lancefield groups A, B, C and G and evidence for a new mef element in group G streptococci that carries allelic variants of mef and msr(D). J Antimicrob Chemother 2006, 57:443-449.
4. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; approved standard. Sixteenth informational supplement. Document M100-S16. Wayne, PA: CLSI; 2006.
5. Blackman Northwood J., Del Grosso M., Cossins L.R., Coley M.D., Creti R., Pantosti A., et al. Characterization of macrolide efflux pump mef subclasses detected in clinical isolates of Streptococcus pyogenes isolated between 1999 and 2005. Antimicrob Agents Chemother 2009, 53:1921-1925.
6. Enright M.C., Spratt B.G., Kalia A., Cross J.H., Bessen D.E. Multilocus sequence typing of Streptococcus pyogenes and the relationships between emm type and clone. Infect Immun 2001, 69:2416-2427.
7. Beall B., Facklam R., Thompson T. Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J Clin Microbiol 1996, 34:953-958.